Lista de obras - Antonio Gómez Caamaño - Dominio Público Uruguay

A genome wide association study (GWAS) providing evidence of an association between common genetic variants and late radiotherapy toxicity

artículo científico publicado en 2014

A three-stage genome-wide association study identifies a susceptibility locus for late radiotherapy toxicity at 2q24.1.

artículo científico publicado en 2014

Adjuvant versus salvage radiotherapy in prostate cancer: multi-institutional retrospective analysis of the Spanish RECAP database.

artículo científico publicado en 2017

Advanced Imaging Techniques in Evaluation of Colorectal Cancer

artículo científico publicado en 2018

Androgen deprivation and radiotherapy in patients with prostate cancer and cardiovascular risk factors: clinical controversies

artículo científico publicado en 2014

Association analyses of more than 140,000 men identify 63 new prostate cancer susceptibility loci

artículo científico publicado en 2018

Association of a XRCC3 polymorphism and rectum mean dose with the risk of acute radio-induced gastrointestinal toxicity in prostate cancer patients.

artículo científico publicado en 2012

Author Correction: Association analyses of more than 140,000 men identify 63 new prostate cancer susceptibility loci

scholarly article published in Nature Genetics

Author Correction: Association analyses of more than 140,000 men identify 63 new prostate cancer susceptibility loci

scholarly article published in Nature Genetics

BRCA1 mutations do not increase prostate cancer risk: results from a meta-analysis including new data

artículo científico publicado en 2011

CT perfusion in oncologic imaging: a useful tool?

artículo científico publicado en 2013

Combined modality therapy in Stage IIIA non-small cell lung cancer: clarity or confusion despite the highest level of evidence? ⬇️

artículo científico publicado en 2017

Common genetic variation associated with increased susceptibility to prostate cancer does not increase risk of radiotherapy toxicity

artículo científico publicado en 2016

Corrigendum to "Uroncor consensus statement: Management of biochemical recurrence after radical radiotherapy for prostate cancer: From biochemical failure to castration resistance". [Rep. Pract. Oncol. Radiother. 20 (2015) 259-272].

artículo científico publicado en 2015

Demand for radiotherapy in Spain

artículo científico publicado en 2016

Development of psoriatic arthritis during nivolumab therapy for metastatic non-small cell lung cancer, clinical outcome analysis and review of the literature.

artículo científico

Evaluating the role of mitochondrial DNA variation to the genetic predisposition to radiation-induced toxicity

article

Fine-mapping of prostate cancer susceptibility loci in a large meta-analysis identifies candidate causal variants.

artículo científico publicado en 2018

Genome-wide association study identifies a region on chromosome 11q14.3 associated with late rectal bleeding following radiation therapy for prostate cancer

artículo científico publicado en 2013

Imaging of Tumor Angiogenesis for Radiologists--Part 1: Biological and Technical Basis

artículo científico

Imaging of Tumor Angiogenesis for Radiologists--Part 2: Clinical Utility

artículo científico

Individual patient data meta-analysis shows a significant association between the ATM rs1801516 SNP and toxicity after radiotherapy in 5456 breast and prostate cancer patients

artículo científico publicado en 2016

Infrastructures, treatment modalities, and workload of radiation oncology departments in Spain with special attention to prostate cancer.

artículo científico publicado en 2013

Low level evidence supporting the choice of optimal multimodality treatment approach in patients with stage IIIA NSCLC- Ain't no mountain high enough…. to keep me getting to you

artículo científico publicado en 2018

Management of prostate cancer patients following radiation therapy after radical surgery referred from urology to radiation oncology departments in Spain

artículo científico publicado en 2015

Meta-analysis of Genome Wide Association Studies Identifies Genetic Markers of Late Toxicity Following Radiotherapy for Prostate Cancer

artículo científico publicado en 2016

No Role For Trimodality Therapy and Consolidation Chemotherapy Compared With Concurrent Radiochemotherapy Alone in Stage III Non-Small-Cell Lung Cancer

artículo científico publicado en 2015

No association between typical European mitochondrial variation and prostate cancer risk in a Spanish cohort

article

Pharmacogenetic analysis in neoadjuvant chemoradiation for rectal cancer: high incidence of somatic mutations and their relation with response.

artículo científico publicado en 2010

Prognostic factors and functional imaging in rectal cancer

scientific article published on 14 October 2011

Quality of life in patients with breakthrough cancer pain in radiation oncology departments in Spain: the CAVIDIOR study

artículo científico publicado en 2020

Radiation Therapy in Extensive Stage Small Cell Lung Cancer.

artículo científico

Surgery for Stage IIIA Non-Small-cell Lung Cancer: Lack of Predictive and Prognostic Factors Identifying Any Subgroup of Patients Benefiting From It.

artículo científico publicado en 2015

TGFβ1 SNPs and radio-induced toxicity in prostate cancer patients

article

The Trimodality Treatment Approach in Stage III/pN2 Non-Small Cell Lung Cancer: "Usually Appropriate" May Well be a Very Inappropriate Treatment Option

artículo científico publicado en 2015

Three linked nomograms for predicting biochemical failure in prostate cancer treated with radiotherapy plus androgen deprivation therapy

artículo científico publicado en 2015

Treatment-Related Predictive and Prognostic Factors in Trimodality Approach in Stage IIIA/N2 Non-Small Cell Lung Cancer.

artículo científico publicado en 2018

Uroncor consensus statement: Management of biochemical recurrence after radical radiotherapy for prostate cancer: From biochemical failure to castration resistance.

artículo científico

Usefulness of bone turnover markers as predictors of mortality risk, disease progression and skeletal-related events appearance in patients with prostate cancer with bone metastases following treatment with zoledronic acid: TUGAMO study

artículo científico publicado en 2013

Lista de obras de Antonio Gómez Caamaño

A genome wide association study (GWAS) providing evidence of an association between common genetic variants and late radiotherapy toxicity

A three-stage genome-wide association study identifies a susceptibility locus for late radiotherapy toxicity at 2q24.1.

Adjuvant versus salvage radiotherapy in prostate cancer: multi-institutional retrospective analysis of the Spanish RECAP database.

Advanced Imaging Techniques in Evaluation of Colorectal Cancer

Androgen deprivation and radiotherapy in patients with prostate cancer and cardiovascular risk factors: clinical controversies

Association analyses of more than 140,000 men identify 63 new prostate cancer susceptibility loci

Association of a XRCC3 polymorphism and rectum mean dose with the risk of acute radio-induced gastrointestinal toxicity in prostate cancer patients.

Author Correction: Association analyses of more than 140,000 men identify 63 new prostate cancer susceptibility loci

Author Correction: Association analyses of more than 140,000 men identify 63 new prostate cancer susceptibility loci

BRCA1 mutations do not increase prostate cancer risk: results from a meta-analysis including new data

CT perfusion in oncologic imaging: a useful tool?

Combined modality therapy in Stage IIIA non-small cell lung cancer: clarity or confusion despite the highest level of evidence? ⬇️

Common genetic variation associated with increased susceptibility to prostate cancer does not increase risk of radiotherapy toxicity

Corrigendum to "Uroncor consensus statement: Management of biochemical recurrence after radical radiotherapy for prostate cancer: From biochemical failure to castration resistance". [Rep. Pract. Oncol. Radiother. 20 (2015) 259-272].

Demand for radiotherapy in Spain

Development of psoriatic arthritis during nivolumab therapy for metastatic non-small cell lung cancer, clinical outcome analysis and review of the literature.

Evaluating the role of mitochondrial DNA variation to the genetic predisposition to radiation-induced toxicity

Fine-mapping of prostate cancer susceptibility loci in a large meta-analysis identifies candidate causal variants.

Genome-wide association study identifies a region on chromosome 11q14.3 associated with late rectal bleeding following radiation therapy for prostate cancer

Imaging of Tumor Angiogenesis for Radiologists--Part 1: Biological and Technical Basis

Imaging of Tumor Angiogenesis for Radiologists--Part 2: Clinical Utility

Individual patient data meta-analysis shows a significant association between the ATM rs1801516 SNP and toxicity after radiotherapy in 5456 breast and prostate cancer patients

Infrastructures, treatment modalities, and workload of radiation oncology departments in Spain with special attention to prostate cancer.

Low level evidence supporting the choice of optimal multimodality treatment approach in patients with stage IIIA NSCLC- Ain't no mountain high enough…. to keep me getting to you

Management of prostate cancer patients following radiation therapy after radical surgery referred from urology to radiation oncology departments in Spain

Meta-analysis of Genome Wide Association Studies Identifies Genetic Markers of Late Toxicity Following Radiotherapy for Prostate Cancer

No Role For Trimodality Therapy and Consolidation Chemotherapy Compared With Concurrent Radiochemotherapy Alone in Stage III Non-Small-Cell Lung Cancer

No association between typical European mitochondrial variation and prostate cancer risk in a Spanish cohort

Pharmacogenetic analysis in neoadjuvant chemoradiation for rectal cancer: high incidence of somatic mutations and their relation with response.

Prognostic factors and functional imaging in rectal cancer

Quality of life in patients with breakthrough cancer pain in radiation oncology departments in Spain: the CAVIDIOR study

Radiation Therapy in Extensive Stage Small Cell Lung Cancer.

Surgery for Stage IIIA Non-Small-cell Lung Cancer: Lack of Predictive and Prognostic Factors Identifying Any Subgroup of Patients Benefiting From It.

TGFβ1 SNPs and radio-induced toxicity in prostate cancer patients

The Trimodality Treatment Approach in Stage III/pN2 Non-Small Cell Lung Cancer: "Usually Appropriate" May Well be a Very Inappropriate Treatment Option

Three linked nomograms for predicting biochemical failure in prostate cancer treated with radiotherapy plus androgen deprivation therapy

Treatment-Related Predictive and Prognostic Factors in Trimodality Approach in Stage IIIA/N2 Non-Small Cell Lung Cancer.

Uroncor consensus statement: Management of biochemical recurrence after radical radiotherapy for prostate cancer: From biochemical failure to castration resistance.

Usefulness of bone turnover markers as predictors of mortality risk, disease progression and skeletal-related events appearance in patients with prostate cancer with bone metastases following treatment with zoledronic acid: TUGAMO study